⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CRBP News
Corbus Pharmaceuticals Holdings, Inc.
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Reports Q1 2026 Financial Results and Provides a Corporate Update
globenewswire.com
CRBP
Corbus Pharmaceuticals to Host In-Person and Virtual KOL Event at ASCO 2026
globenewswire.com
CRBP
Exosome Therapy Market Size and Industry Dynamics 2026-2035 - Standardization Challenges Loom Over Booming $58 Billion Exosome Therapy Industry
globenewswire.com
CRBP
CAPR
AEMD
COYA
EVOX
Corbus Pharmaceuticals Announces Abstracts Accepted for Presentation at ASCO 2026 Featuring Updated Clinical Data for CRB-701
globenewswire.com
CRBP
Form 8-K
sec.gov
CRBP
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
globenewswire.com
CRBP
Form 8-K
sec.gov
CRBP
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
globenewswire.com
CRBP